And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...
On anti-obesity day, a transformation journey of a man who beat obesity and sleep apnea with diet, exercise and sleep ...
Pvolve is a low-impact workout that's skyrocketing in popularity thanks in part to its celebrity fans, including Jennifer ...
Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...
A personalised, moderately restricted low-protein diet was feasible in patients with advanced chronic kidney disease (CKD), with over 60% adherence. Patients who chose and followed the diet had a ...
Merck, the company that introduced statins to the world nearly 40 years ago, has a new, intensely powerful pill that can slash levels of dangerous LDL cholesterol to levels almost never seen in adults ...
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk. By Gina Kolata Merck, the company that introduced statins to the ...
When real-estate agent Jo Chavez first showed her buyers a $400,000 four-bedroom property in Kansas City, Mo., she thought she saw the light at the end of the tunnel. The buyers had been looking for ...
Halloween can be an expensive holiday, but achieving a festive look doesn’t require a designer budget or a trip to a pricey specialty store. This year, consumers embrace the creative challenge of ...
Rep. Jake Auchincloss on the FBI seeking to interview lawmakers featured in a video urging troops to disobey illegal orders ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X BERTHOUD — Kevin Dougherty knew a low round was coming. The California native, who went to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results